Study to Evaluate Efficacy and Dose Response of Imapextide (STEADI)

Clinical trial NCT07029412 · COMPLETED

Trial details

NCT number: NCT07029412
Sponsor: MBX Biosciences
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Postbariatric Hypoglycemia

Start date: 2025-08-26
Primary completion: 2026-04-18
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.